CN203001479U - Cetirizine hydrochloride tablet - Google Patents

Cetirizine hydrochloride tablet Download PDF

Info

Publication number
CN203001479U
CN203001479U CN 201220500371 CN201220500371U CN203001479U CN 203001479 U CN203001479 U CN 203001479U CN 201220500371 CN201220500371 CN 201220500371 CN 201220500371 U CN201220500371 U CN 201220500371U CN 203001479 U CN203001479 U CN 203001479U
Authority
CN
China
Prior art keywords
cetirizine hydrochloride
hydrochloride tablets
utility
tablets
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201220500371
Other languages
Chinese (zh)
Inventor
张凯
谢雁鸣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Guoyuan Sinopharm Co., Ltd.
Original Assignee
SHENZHEN GUOYUAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN GUOYUAN PHARMACEUTICAL CO Ltd filed Critical SHENZHEN GUOYUAN PHARMACEUTICAL CO Ltd
Priority to CN 201220500371 priority Critical patent/CN203001479U/en
Application granted granted Critical
Publication of CN203001479U publication Critical patent/CN203001479U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

The utility model is suitable for the technical field of pharmacy, and provides a cetirizine hydrochloride tablet which is a special-shaped tablet with a notch disposed at the central part of the cetirizine hydrochloride tablet. According to the utility model, the cetirizine hydrochloride tablet is prepared into a special-shaped tablet with a notch disposed at the central part, and thus the drug dosage can be distributed with the notch as a boundary, which is accurate in dosage distribution and convenient for patients.

Description

Cetirizine hydrochloride Tablets
Technical field
This utility model belongs to the pharmaceutical technology field, relates in particular to a kind of Cetirizine hydrochloride Tablets.
Background technology
Cetirizine hydrochloride belongs to the Western medicine kind, is mainly used in seasonality or catarrhus perennialis and the urticaria that caused by anaphylactogen and skin pruritus etc.This medicine is made into capsule usually, is difficult to accurately distribute dosage according to practical situation, makes troubles to the patient.
The utility model content
The purpose of this utility model embodiment is to provide a kind of Cetirizine hydrochloride Tablets, is intended to solve existing Cetirizine hydrochloride Tablets dosage and distributes not accurate enough problem.
This utility model embodiment is achieved in that a kind of Cetirizine hydrochloride Tablets, is that reeded special-shaped tablets is established at the middle part.
This utility model embodiment makes the middle part with Cetirizine hydrochloride Tablets and is with reeded special-shaped tablets, can groove be that the boundary distributes dosage like this, makes up a prescription accurately, gives the patient with convenient.
Description of drawings
Fig. 1 is the top view of the Cetirizine hydrochloride Tablets that provides of this utility model embodiment;
Fig. 2 is the side view of the Cetirizine hydrochloride Tablets that provides of this utility model embodiment.
The specific embodiment
In order to make the purpose of this utility model, technical scheme and advantage clearer, below in conjunction with drawings and Examples, this utility model is further elaborated.Should be appreciated that specific embodiment described herein only in order to explaining this utility model, and be not used in restriction this utility model.
This utility model embodiment makes the middle part with Cetirizine hydrochloride Tablets and is with reeded special-shaped tablets, can groove be that the boundary distributes dosage like this, makes up a prescription accurately, gives the patient with convenient.
Below in conjunction with specific embodiment, realization of the present utility model is described in detail.
As shown in Figure 1, 2, the Cetirizine hydrochloride Tablets system middle part that this utility model embodiment provides is provided with the special-shaped tablets of groove 10, can be boundary's distribution dosage by groove 10 like this, gives the patient with convenient.For example, half that the children amount is grown up often perhaps in particular cases, when dosage need reduce by half, only needs this Cetirizine hydrochloride Tablets is broken off with the fingers and thumb into two along groove 10 to get final product.
Usually, described Cetirizine hydrochloride Tablets is strip, and long L is 8 ~ 12mm, and wide W is 3 ~ 5mm, and high H is 3 ~ 5mm.So size, make whole Cetirizine hydrochloride Tablets dosage suitable, and the figure is well-balanced.Wherein, it is the arcuation convex surface 11 of 180 ° that described Cetirizine hydrochloride Tablets arranged on left and right sides is respectively established a central angle, and described arcuation convex surface 11 position of living in thickness T is 1.5 ~ 2.5mm.Make like this this Cetirizine hydrochloride Tablets round and smooth, be convenient to take.
In addition, the upper and lower end face of described Cetirizine hydrochloride Tablets is cambered surface 12.So make whole Cetirizine hydrochloride Tablets be streamlined, resistance suffered when it moves in fluid (as air, water) is less.When the patient swallows, this Cetirizine hydrochloride Tablets will be passed through throat smoothly, make the swallower feel comfortable, and the dysphagia patients such as the old man that is highly advantageous to, child are swallowed, and patient compliance is good.As preferably, the central angle of described cambered surface 12 is 100 ~ 110 °.
The above is only preferred embodiment of the present utility model; not in order to limit this utility model; all any modifications of doing within spirit of the present utility model and principle, be equal to and replace and improvement etc., within all should being included in protection domain of the present utility model.

Claims (4)

1. a Cetirizine hydrochloride Tablets, is characterized in that, described Cetirizine hydrochloride Tablets system establishes reeded special-shaped tablets in the middle part; Described Cetirizine hydrochloride Tablets is strip, and length is 8~12mm, and wide is 3~5mm, and height is 3~5mm.
2. Cetirizine hydrochloride Tablets as claimed in claim 1, is characterized in that, it is the arcuation convex surface of 180 ° that described Cetirizine hydrochloride Tablets arranged on left and right sides is respectively established a central angle, and described arcuation convex surface position of living in thickness is 1.5~2.5mm.
3. Cetirizine hydrochloride Tablets as claimed in claim 1 or 2, is characterized in that, the upper and lower end face of described Cetirizine hydrochloride Tablets is cambered surface.
4. Cetirizine hydrochloride Tablets as claimed in claim 3, is characterized in that, the central angle of described cambered surface is 100~110 °.
CN 201220500371 2012-09-27 2012-09-27 Cetirizine hydrochloride tablet Expired - Fee Related CN203001479U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201220500371 CN203001479U (en) 2012-09-27 2012-09-27 Cetirizine hydrochloride tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201220500371 CN203001479U (en) 2012-09-27 2012-09-27 Cetirizine hydrochloride tablet

Publications (1)

Publication Number Publication Date
CN203001479U true CN203001479U (en) 2013-06-19

Family

ID=48593117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201220500371 Expired - Fee Related CN203001479U (en) 2012-09-27 2012-09-27 Cetirizine hydrochloride tablet

Country Status (1)

Country Link
CN (1) CN203001479U (en)

Similar Documents

Publication Publication Date Title
AU2012271836A8 (en) Mask for administration of inhaled medication
CN203001479U (en) Cetirizine hydrochloride tablet
CN204106443U (en) A kind of Mobile medical oral medicine car
CN202526620U (en) Plaster with health care recovery function
CN204542893U (en) A kind of medicine nursing multifunction storage medicated bag
CN203524989U (en) Convenient eyedrop bottle
CN202620274U (en) Secnidazole tablet
CN202151439U (en) Heart-protecting musk pills being convenient to take
CN205598258U (en) Tablet
CN204050316U (en) One is taken medicine and is used timesharing medicine taking box
CN201888272U (en) Kneepad
CN202161589U (en) Danning tablet convenient to take
CN202620273U (en) Gynecological inflammation treatment dispersible tablet
CN103479521A (en) Multifunctional medicine box for old people and medication managing and reminding method
CN203005996U (en) Medicine bag
CN202314445U (en) Novel medicament taking device for pharmacy department
CN202161585U (en) Fuyankang dispersible tablet
CN205198489U (en) Special medicine feed ware of children
CN202022465U (en) Convenient and fast drug bottle
CN201139330Y (en) Novel pillow
CN109160099A (en) A kind of Chinese medicine case
CN202366185U (en) Medicine distributing and containing device for oral medicines for cardiology department patients
CN201790436U (en) Adjustable pillow with healthcare function
CN205513783U (en) Medical pillow
CN202802164U (en) Chinese herbal medicine temporary storage box for getting medicine in pharmacy

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: SHENZHEN GUOYUAN CHINESE MEDICINE CO., LTD.

Free format text: FORMER NAME: SHENZHEN GUOYUAN PHARMACEUTICAL CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 518000, Guangdong District, Shenzhen, Longgang Province on the South Bay Street Li Long community, Li Lang North Road No. 5 workshop 4-5, building 101, 3, B District

Patentee after: Shenzhen Guoyuan Sinopharm Co., Ltd.

Address before: 518000, Guangdong District, Shenzhen, Longgang Province on the South Bay Street Li Long community, Li Lang North Road No. 5 workshop 4-5, building 101, 3, B District

Patentee before: Shenzhen Guoyuan Pharmaceutical Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130619

Termination date: 20160927

CF01 Termination of patent right due to non-payment of annual fee